The net outcomes of the above mechanisms result in an increase in chronic low-grade inflammation, a reduction in glycogen synthesis, a gain in lipogenesis, and a raising in blood insulin and glucose levels, eventually resulted in steatosis in NAFLD (8). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.